BridgeMD
Aspirin in immune thrombocytopenia patients with cardiovascular disease
EU CTIS ID: 2024-513846-13-00
What this study is testing
To assess the residual platelet function after 75 mg aspirin intake (H24)
- Phase III and phase IV (Integrated)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- adult patients (sup 18-year-old)
- non-treated ITP or ITP with stable treatment (at least 1 month)
- treated with aspirin daily for a cardiovascular disease
- stable platelet count < 100 x 109/L
- at least one month following an arterial thrombosis; no other antiplatelet drug
- female patient with childbearing potential must have acceptable method of birth control
You likely can't join if
- opposition to participate
- adults Under guardianship or other legal protection, deprived of their liberty by judicial or administrative decision
- pregnancy or breastfeeding
See the full eligibility criteria
- adult patients (sup 18-year-old)
- non-treated ITP or ITP with stable treatment (at least 1 month)
- treated with aspirin daily for a cardiovascular disease
- stable platelet count < 100 x 109/L
- at least one month following an arterial thrombosis; no other antiplatelet drug
- female patient with childbearing potential must have acceptable method of birth control
- affiliated or benefiting from public health insurance.
- opposition to participate
- adults Under guardianship or other legal protection, deprived of their liberty by judicial or administrative decision
- pregnancy or breastfeeding
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years, 65+ years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.